Cambridge Investment Research Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.9 Billion
Q4 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 4,330 shares of REGN stock, worth $3.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,330

Previous 5,344 18.97%

Holding current value

$3.23 Million

Previous $5.62 Million 45.11%

% of portfolio

0.01%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$701.85 - $1046.91 $711,675 - $1.06 Million	-1,014 Reduced 18.97%	4,330 $3.08 Million
Q3 2024 Oct 28, 2024	BUY	$1024.09 - $1201.76 $166,926 - $195,886	163 Added 3.15%	5,344 $5.62 Million
Q2 2024 Jul 26, 2024	SELL	$883.2 - $1071.19 $52,108 - $63,200	-59 Reduced 1.13%	5,181 $5.45 Million
Q1 2024 Apr 24, 2024	SELL	$902.69 - $993.35 $2.6 Million - $2.86 Million	-2,883 Reduced 35.49%	5,240 $5.04 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $1.55 Million - $1.77 Million	-2,003 Reduced 19.78%	8,123 $7.13 Million
Q3 2023 Oct 24, 2023	BUY	$692.45 - $844.37 $4.04 Million - $4.92 Million	5,832 Added 135.82%	10,126 $8.33 Million
Q2 2023 Jul 13, 2023	SELL	$700.03 - $830.35 $1.04 Million - $1.23 Million	-1,487 Reduced 25.72%	4,294 $3.09 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $430,069 - $522,645	-632 Reduced 9.85%	5,781 $4.75 Million
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $501,181 - $544,136	-710 Reduced 9.97%	6,413 $4.63 Million
Q3 2022 Oct 17, 2022	SELL	$573.97 - $724.32 $1.45 Million - $1.83 Million	-2,529 Reduced 26.2%	7,123 $4.91 Million
Q2 2022 Jul 13, 2022	SELL	$548.35 - $738.84 $155,183 - $209,091	-283 Reduced 2.85%	9,652 $5.71 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $387,423 - $454,677	-651 Reduced 6.15%	9,935 $6.94 Million
Q4 2021 Feb 03, 2022	BUY	$543.48 - $670.97 $278,805 - $344,207	513 Added 5.09%	10,586 $6.69 Million
Q3 2021 Nov 02, 2021	SELL	$574.03 - $680.96 $1.05 Million - $1.24 Million	-1,825 Reduced 15.34%	10,073 $6.1 Million
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $197,157 - $232,911	417 Added 3.63%	11,898 $6.65 Million
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $1 Million - $1.23 Million	-2,246 Reduced 16.36%	11,481 $5.43 Million
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $1.35 Million - $1.72 Million	2,823 Added 25.89%	13,727 $6.63 Million
Q3 2020 Oct 29, 2020	SELL	$544.75 - $658.21 $2.17 Million - $2.62 Million	-3,981 Reduced 26.75%	10,904 $6.1 Million
Q2 2020 Jul 27, 2020	BUY	$493.32 - $643.92 $3.27 Million - $4.26 Million	6,622 Added 80.14%	14,885 $9.28 Million
Q1 2020 May 08, 2020	SELL	$336.18 - $494.43 $1.24 Million - $1.83 Million	-3,694 Reduced 30.89%	8,263 $4.03 Million
Q4 2019 Feb 04, 2020	BUY	$274.13 - $376.51 $51,536 - $70,783	188 Added 1.6%	11,957 $4.49 Million
Q3 2019 Nov 06, 2019	SELL	$273.46 - $318.39 $405,541 - $472,172	-1,483 Reduced 11.19%	11,769 $3.26 Million
Q2 2019 Aug 15, 2019	BUY	$299.6 - $414.82 $299 - $414	1 Added 0.01%	13,252 $0
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $184,179 - $217,587	495 Added 3.88%	13,251 $0
Q4 2018 Feb 05, 2019	BUY	$335.82 - $403.04 $491,304 - $589,647	1,463 Added 12.95%	12,756 $4.76 Million
Q3 2018 Nov 02, 2018	SELL	$351.14 - $408.51 $229,645 - $267,165	-654 Reduced 5.47%	11,293 $0
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $136,323 - $165,250	479 Added 4.18%	11,947 $0
Q1 2018 May 09, 2018	BUY	$315.82 - $393.78 $684,066 - $852,927	2,166 Added 23.29%	11,468 $0
Q4 2017 Feb 22, 2018	BUY	$358.63 - $469.95 $91,809 - $120,307	256 Added 2.83%	9,302 $0
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $2.76 Million - $3.22 Million	6,387 Added 240.2%	9,046 $4.05 Million
Q2 2017 Aug 08, 2017	BUY	N/A	2,659	2,659 $1.31 Million

Others Institutions Holding REGN

# of Institutions

1,492

Shares Held

85.8M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History